TIMP2 and breast cancer: Clarke et al. [29] found that the presence of TIMP-1 and TIMP-2, which are inhibitors of MMPs, in the secretome of immortalized BM-MSC led to the inhibition of breast cancer cell movement, with a better response towards invasiveness than migration.